Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Current Assets (2020 - 2026)

Sight Sciences has reported Current Assets over the past 6 years, most recently at $112.7 million for Q4 2025.

  • For Q4 2025, Current Assets fell 19.35% year-over-year to $112.7 million; the TTM value through Dec 2025 reached $112.7 million, down 19.35%, while the annual FY2025 figure was $112.7 million, 19.35% down from the prior year.
  • Current Assets for Q4 2025 was $112.7 million at Sight Sciences, down from $113.6 million in the prior quarter.
  • Over five years, Current Assets peaked at $287.8 million in Q3 2021 and troughed at $47.4 million in Q2 2021.
  • A 5-year average of $173.7 million and a median of $162.9 million in 2023 define the central range for Current Assets.
  • On a YoY basis, Current Assets climbed as much as 401.22% in 2022 and fell as far as 24.31% in 2022.
  • Year by year, Current Assets stood at $277.0 million in 2021, then fell by 24.31% to $209.7 million in 2022, then dropped by 22.32% to $162.9 million in 2023, then dropped by 14.18% to $139.8 million in 2024, then dropped by 19.35% to $112.7 million in 2025.
  • Business Quant data shows Current Assets for SGHT at $112.7 million in Q4 2025, $113.6 million in Q3 2025, and $119.4 million in Q2 2025.